Port Erin Biopharma Investments LTD (PEBI)

 

PEBI Share PerformanceMore

52 week high10.000 31/12/15
52 week low3.900 05/04/16
52 week change 0.750 (10.34%)
4 week volume1,514,149 06/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Net Asset Value(s)

RNS Number: 2753M Port Erin Biopharma Investments Ltd 12 October 2016 12 October 2016 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 30 September 2016 Jim Mellon, Chairman, commented: - "The Net Asset Value ("NAV") calculation for the Company as at closing on 30 September 2016 was 9.96 pence per share, inclu...

Net Asset Value(s)

RNS Number: 9138E Port Erin Biopharma Investments Ltd 22 July 2016 22 July 2016 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 30 June 2016 Jim Mellon, Chairman, commented: - "The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2016 was 9.28 pence per share, including un-invested ca...

Net Asset Value calculation to 31 March 2016

RNS Number: 7471W Port Erin Biopharma Investments Ltd 28 April 2016 29 April 2016 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 31 March 2016 Jim Mellon, Chairman, commented: - "The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2016 was 10.21 pence per share, including un-inv...

Port Erin appoints nomad and joint broker

Port Erin Biopharma Investments has announced the appointment of Northland Capital Partners Limited as the Company...

Change of Adviser

RNS Number: 2799V Port Erin Biopharma Investments Ltd 15 April 2016 Port Erin Biopharma Investments Limited ("Port Erin" or the "Company") Change of Adviser The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the appointment of Northland Capital Partners Li...

Holding(s) in Company

RNS Number: 4991S Port Erin Biopharma Investments Ltd 18 March 2016 18 March 2016 Port Erin Biopharma Investments Limited (the "Company") The Company has been informed today that the 2,715,614 Ordinary Shares held by Shellbay Investments Limited have been transferred to Galloway Limited. As a result, Galloway Limited is now interested in 5,455,313 O...

Port Erin Biopharma widens H1 pretax loss

Port Erin Biopharma has widened its H1 pretax loss to GBP0.18m, from GBP0.14m. Investment income was -GBP96,448, from...

Interim Results for the six months to 31 Dec 2015

RNS Number: 3594S Port Erin Biopharma Investments Ltd 17 March 2016 17 March 2016 Port Erin Biopharma Investments Limited ("Port Erin" or the "Company") Interim Results for the six-month period ending 31 December 2015 The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased t...

Fundamental DataMore

EPS-2.03
Dividend yield0 %

Latest discussion posts More

  • Re: Regent Pacific continuing to move up

    Thanks. Agree that the NAV is about 12.2p or thereabouts (would be interested in seeing your calculation, as 12.4p is what I worked out at today's prices, including the ...
    29-Nov-2016
    casper72
  • Regent Pacific continuing to move up

    Regent Pacific up almost another 20% to 0.72 overnight in HK.... On another bb we calculated the NAV now to be around 12.2p, and that was before this move up for RP. An ...
    25-Nov-2016
    gretel
  • Price getting to (or above) fair value

    This is truly a share that keeps giving (at least to me) so I know if will seem weird to give a sell recommendation. But nonetheless I would sell if the bid goes above 9p. I ...
    25-Nov-2016
    casper72

Users' HoldingsMore

Users who hold Port Erin Biopharma Investments LTD also hold..
LENOVO33%
REDSTONECON33%
CHINA NEW33%
AMUR MINERALS33%
UNION JACK33%

Codes & Symbols

ISINIM00B6QH1J21
SymbolsPEBI, LSE:PEBI, PEBI.L, PEBI:LN, LON:PEBI, XLON:PEBI